Anadolu Medical Center
| Türkei | Österreich | Spanien | |
| Strahlentherapie bei Nierenkrebs | von $6,500 | - | von $4,707 |
Tag 1 – Ankunft
Tag 2 – Voroperation
Tag 3 – Voroperation
Tag 4 – Strahlentherapie
Tag 5 – Nach der Operation
Woche 1 bis 2 – Rehabilitation
Woche 3 bis 4 – Rehabilitation
Woche 5 – Rehabilitation
Bitte beachten Sie, dass der Fall jedes Patienten individuell ist und der oben genannte Zeitrahmen je nach Zustand des Patienten und Ansprechen auf die Behandlung variieren kann.
Dr. Solak ist am Hisar Hospital Intercontinental auf Strahlentherapie bei Nierenkrebs spezialisiert und wurde am Hacettepe University Cancer Institute ausgebildet.
Dr. Banu Atalar ist Fachärztin für Strahlentherapie (Türkei, 2004). Sie ist seit 2018 Professorin an der Acibadem MAA University und seit 2026 klinisch am Anadolu Medical Center tätig. Ihre Ausbildung absolvierte sie an den Universitäten Istanbul und Cerrahpaşa. 2011 schloss sie ein klinisches Forschungsstipendium an der Stanford University in stereotaktischer Radiochirurgie ab. Ihr Schwerpunkt liegt auf Tumoren des ZNS, des Thorax und des Gastrointestinaltrakts. Rund 75 % ihrer Behandlungen entfallen auf SRS (stereotaktische Radiochirurgie) und MR‑geführte adaptive SRS.
Zu ihren Auszeichnungen zählen der ASCO IDEA Award (2004), der IASLC International Mentorship Award (2018) und H.FACR (2025). Sie hat 72 internationale, peer‑reviewte Publikationen. Zu ihren Leitungsfunktionen zählen die Präsidentschaft der Türkischen Gesellschaft für Radioonkologie (2025–27) und der Vorsitz des ESTRO National Societies Committee (2024–27). Sie war Mitglied des ASCO Resource‑Stratified Guidelines Committee (2013–18) sowie der RSS‑Tagungs- und Nominierungsausschüsse. Sie organisierte nationale Kongresse (2023, 2025) und war als eingeladene Referentin auf großen Fachkongressen vertreten.
Professor Dr. Sefik Igdem ist am Gayrettepe Florence Nightingale Hospital auf Radioonkologie mit fortschrittlichen Technologien wie Truebeam Stx und Halcyons spezialisiert.
Dr. Mehmet Doğu Canoğlu ist Radioonkologe. Er schloss sein Medizinstudium an der Medizinischen Fakultät der Universität Kocaeli ab. Von 2006 bis 2012 absolvierte er dort seine Facharztausbildung in Radioonkologie.
Seinen Pflichtdienst leistete er am Ausbildungs- und Forschungskrankenhaus Diyarbakır. Anschließend arbeitete er am Ausbildungs- und Forschungskrankenhaus Bağcılar und von 2015 bis 2017 am Medipol Mega Universitätskrankenhaus. Seit 2017 ist er Radioonkologe am Anadolu Medical Center.
Radiation therapy is highly effective for specific kidney cancer cases but not as a primary cure. Modern SBRT achieves over 90% local control for inoperable tumors and metastatic sites. In Turkey, oncology centers like Memorial and Anadolu Medical Center utilize advanced technologies like CyberKnife under JCI accreditation.
Bookimed Expert Insight: Turkey's top oncology hospitals share a key trait: direct partnerships with leading US institutions. Anadolu Medical Center is affiliated with Johns Hopkins, and doctors like Prof. Banu Atalar trained at Stanford. This link ensures treatment protocols match global best practices for complex radiation cases.
Patient Consensus: Patients describe radiation as a crucial tool for managing metastatic pain, with some achieving significant tumor shrinkage for extended mobility, but many note it's typically considered after other options like surgery or immunotherapy.
International patients can expect coordinated VIP logistics in Turkey's JCI-accredited oncology centers, including private airport transfers, English-speaking coordinators, and accommodation near hospitals like Memorial Şişli and Anadolu Medical Center. Most clinics handle scheduling within days using systems like TrueBeam STx, and they provide follow-up plans in English.
Bookimed Expert Insight: Clinics handling 500,000 international patients annually rely on streamlined systems. Anadolu Medical Center, for instance, assigns coordinators like Zakhida for language and transport. This volume explains why radiation therapy fractions for kidney cancer often begin just days after arrival.
Patient Consensus: Patients emphasize confirming the fraction count for SBRT upfront and using WhatsApp for 24/7 contact with coordinators. They recommend JCI-accredited hospitals for reliable English support to navigate Istanbul's busy traffic.
Radiation treatment for kidney cancer in Turkey typically lasts 1–6 weeks, depending on the technique. Stereotactic body radiation therapy (SBRT) is a high-dose short-course treatment requiring 3–5 sessions over 1–2 weeks. Conventional fractionated radiotherapy requires daily sessions for 6+ weeks.
Bookimed Expert Insight: Turkey's top clinics offer the fastest SBRT protocols. Anadolu Medical Center uses MR-Linac guided adaptive SRS, which can condense treatment. Dr. Banu Atalar there is an international SRS expert and committee chair. Memorial Şişli Hospital also offers advanced Elekta Versa HD technology.
Patient Consensus: Patients confirm SBRT for kidney tumors is quick, taking 1–2 weeks total. They advise planning for lingering fatigue that may last 1–3 months after the final session.
Top Turkish hospitals for kidney cancer radiation therapy include Anadolu Medical Center and Memorial Şişli Hospital in Istanbul, offering CyberKnife, TrueBeam STx, and proton therapy within JCI-accredited facilities and staffed by U.S.-trained specialists like Prof. Banu Atalar.
Bookimed Expert Insight: The data reveals a concentration of advanced SRS and proton therapy in Istanbul's largest JCI networks. For kidney cancer, clinics with the highest patient volumes, like Memorial and Anadolu, correlate with specialist doctors who have top-tier international training, such as Stanford or MD Anderson fellowships.
Patient Consensus: Patients report choosing Turkey for faster treatment turnarounds than in the EU, noting the importance of verifying JCI accreditation upfront and confirming hotel inclusions when negotiating treatment packages.
Turkish oncology clinics offer cutting-edge radiation technologies like SBRT, MR-guided linear accelerators (MR-Linac), CyberKnife robotic systems, and Varian platforms such as TrueBeam STx and Halcyon. These technologies, available at top JCI-accredited centers, enable real-time tumor tracking and highly conformal doses to preserve kidney function.
Bookimed Expert Insight: The technology mix reveals a clinic's focus. Medipol Bahçelievler is brand-new and pushes TrueBeam STx and Halcyon systems for speed and conformity. Anadolu and Medipol Mega center on CyberKnife and Gamma Knife for radiosurgery. Your doctor’s specialization is key—experts like Dr. Berrin Pehlivan bring proton therapy research to the table, which is rare in Turkey.
Patient Consensus: Patients consistently advise verifying the specific linear accelerator model and planning software, as this matters more than location. Many note the effectiveness of SBRT for early-stage disease, preferring its 3-5 sessions over longer conventional treatment.
Typical side effects of kidney radiation include short-term fatigue, urinary changes, and localized skin reactions which generally resolve within weeks. In Turkey, treatments using high-precision SBRT, CyberKnife, or MR Linac at JCI-accredited facilities help minimize risks, with patients undergoing regular creatinine monitoring for kidney function.
Bookimed Expert Insight: Turkey's leading clinics make proactive symptom management a priority. Anadolu Medical Center, for example, provides English-speaking doctors for clear communication, and Medipol Bahçelievler uses advanced TrueBeam and Halcyon systems to precisely target tumors. This focus on patient guidance and precise technology helps manage common effects like fatigue and urinary changes.
Patient Consensus: Many patients report fatigue starting around week two, and find that short walks and staying hydrated help more than expected. They also emphasize starting anti-nausea routines early and wearing loose clothing to manage skin reactions.